Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose

Conditions:   Opioid-Use Disorder;   Opioid Overdose Intervention:   Drug: Buprenorphine extended-release injection Sponsors:   M. Eugenia Socias;   Indivior Inc. Not yet recruiting

Source: ClinicalTrials.gov - March 25, 2021 Category: Research Source Type: clinical trials